Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2021-08-18

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$559.8m reported value -16.7% vs Q1 2021
153positions
31.3%in top 10
18 new 27 added 49 reduced 43 sold out vs Q1 2021

Options: 37 call positions ($457.5m notional), 20 put positions ($219.8m notional) – listed below, not included above.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOGEN INC COM BIIB BIIB 125,962 $43.6m7.79% 7.79% AddedShares held: Q3 2020 3.0k, Q4 2020 5.7k, Q1 2021 5.7k, Q2 2021 126.0k +120.3k +120,262 2109.9%
2 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 119,711 $19.4m3.46% 3.46% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 15.1k, Q2 2021 119.7k +104.6k +104,627 693.6%
3 X4 PHARMACEUTICALS INC COM COM 2,719,290 $17.7m3.16% 3.16% AddedShares held: Q3 2020 724.7k, Q4 2020 826.4k, Q1 2021 2.6m, Q2 2021 2.7m +104.3k +104,302 4.0%
4 TRACON PHARMACEUTICALS INC COM NEW COM NEW 2,716,840 $17.6m3.15% 3.15% UnchangedShares held: Q3 2020 2.2m, Q4 2020 2.7m, Q1 2021 2.7m, Q2 2021 2.7m
5 ALECTOR INC COM ALEC ALEC 674,723 $14.1m2.51% 2.51% AddedShares held: Q3 2020 321, Q4 2020 57.5k, Q1 2021 257.5k, Q2 2021 674.7k +417.2k +417,223 162.0%
6 GALAPAGOS NV SPON ADR LKFT LKFT 200,000 $13.9m2.48% 2.48% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k
7 CHIMERIX INC COM CMRX CMRX 1,575,916 $12.6m2.25% 2.25% ReducedShares held: Q3 2020 1.4m, Q4 2020 1.2m, Q1 2021 1.6m, Q2 2021 1.6m -21.6k -21,598 -1.4%
8 MACROGENICS INC COM MGNX MGNX 459,602 $12.3m2.21% 2.21% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.5k, Q2 2021 459.6k -40.9k -40,867 -8.2%
9 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 365,544 $12.2m2.18% 2.18% ReducedShares held: Q3 2020 1.5m, Q4 2020 1.4m, Q1 2021 596.3k, Q2 2021 365.5k -230.7k -230,746 -38.7%
10 XENON PHARMACEUTICALS INC COM XENE XENE 640,606 $11.9m2.13% 2.13% AddedShares held: Q3 2020 223.2k, Q4 2020 223.2k, Q1 2021 640.6k, Q2 2021 640.6k +30 +30 0.0%
11 MILESTONE PHARMACEUTICALS IN COM MIST MIST 1,980,400 $10.9m1.95% 1.95% AddedShares held: Q3 2020 1.7m, Q4 2020 1.8m, Q1 2021 1.8m, Q2 2021 2.0m +143.9k +143,855 7.8%
12 SIERRA ONCOLOGY INC COM NEW COM NEW 545,002 $10.6m1.90% 1.90% AddedShares held: Q3 2020 313.9k, Q4 2020 318.9k, Q1 2021 445.2k, Q2 2021 545.0k +99.8k +99,814 22.4%
13 VAXCYTE INC COM PCVX PCVX 448,110 $10.1m1.80% 1.80% ReducedShares held: Q3 2020 16.1k, Q4 2020 276.1k, Q1 2021 501.1k, Q2 2021 448.1k -53.0k -53,000 -10.6%
14 RELMADA THERAPEUTICS INC COM RLMD RLMD 300,207 $9.6m1.72% 1.72% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 290.2k, Q2 2021 300.2k +10.0k +10,000 3.5%
15 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 230,889 $9.4m1.68% 1.68% ReducedShares held: Q3 2020 241.0k, Q4 2020 281.0k, Q1 2021 331.0k, Q2 2021 230.9k -100.1k -100,100 -30.2%
16 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 1,356,048 $9.0m1.61% 1.61% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.3m, Q2 2021 1.4m +100.0k +100,000 8.0%
17 ANNOVIS BIO INC COM ANVS ANVS 103,527 $8.9m1.58% 1.58% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 193.4k, Q2 2021 103.5k -89.8k -89,841 -46.5%
18 GOSSAMER BIO INC COM GOSS GOSS 1,048,383 $8.5m1.52% 1.52% UnchangedShares held: Q3 2020 582.5k, Q4 2020 1.0m, Q1 2021 1.0m, Q2 2021 1.0m
19 CABALETTA BIO INC COM CABA CABA 947,128 $8.1m1.46% 1.46% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 389.4k, Q2 2021 947.1k +557.7k +557,744 143.2%
20 CULLINAN THERAPEUTICS INC COM CGEM CGEM 295,596 $7.6m1.36% 1.36% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.0k, Q2 2021 295.6k +294.6k +294,596 29459.6%
21 ODONATE THERAPEUTICS INC COM COM 1,986,412 $6.9m1.24% 1.24% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.3m, Q2 2021 2.0m +650.0k +650,000 48.6%
22 SCPHARMACEUTICALS INC COM SCPH SCPH 1,095,024 $6.7m1.20% 1.20% ReducedShares held: Q3 2020 1.5m, Q4 2020 1.5m, Q1 2021 1.3m, Q2 2021 1.1m -213.7k -213,675 -16.3%
23 CLOVIS ONCOLOGY INC COM CLVS CLVS 1,129,473 $6.6m1.17% 1.17% AddedShares held: Q3 2020 756.2k, Q4 2020 642.1k, Q1 2021 679.5k, Q2 2021 1.1m +450.0k +450,000 66.2%
24 CHEMOCENTRYX INC COM CCXI CCXI 471,376 $6.3m1.13% 1.13% NewShares held: Q3 2020 37, Q4 2020 37, Q1 2021 0, Q2 2021 471.4k
25 OCULAR THERAPEUTIX INC COM OCUL OCUL 419,573 $6.0m1.06% 1.06% UnchangedShares held: Q3 2020 1.7m, Q4 2020 684.6k, Q1 2021 419.6k, Q2 2021 419.6k
26 PROTARA THERAPEUTICS INC COM STK TARA TARA 584,804 $5.7m1.02% 1.02% ReducedShares held: Q3 2020 722.4k, Q4 2020 649.5k, Q1 2021 649.5k, Q2 2021 584.8k -64.7k -64,738 -10.0%
27 VERASTEM INC COM COM 1,394,394 $5.7m1.01% 1.01% ReducedShares held: Q3 2020 1.4m, Q4 2020 2.3m, Q1 2021 2.7m, Q2 2021 1.4m -1.3m -1,300,000 -48.2%
28 VINCERX PHARMA INC COM NEW COM NEW 426,743 $5.5m0.99% 0.99% ReducedShares held: Q3 2020 0, Q4 2020 538.7k, Q1 2021 438.7k, Q2 2021 426.7k -11.9k -11,941 -2.7%
29 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 290,534 $5.5m0.99% 0.99% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 290.5k
30 SHATTUCK LABS INC COM STTK STTK 190,330 $5.5m0.99% 0.99% UnchangedShares held: Q3 2020 0, Q4 2020 65.0k, Q1 2021 190.3k, Q2 2021 190.3k
31 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 54,815 $5.1m0.92% 0.92% AddedShares held: Q3 2020 2.6k, Q4 2020 0, Q1 2021 603, Q2 2021 54.8k +54.2k +54,212 8990.4%
32 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 209,866 $5.1m0.91% 0.91% AddedShares held: Q3 2020 56.0k, Q4 2020 56.0k, Q1 2021 6.0k, Q2 2021 209.9k +203.9k +203,858 3393.1%
33 LYRA THERAPEUTICS INC COM LYRA LYRA 624,684 $5.0m0.90% 0.90% ReducedShares held: Q3 2020 387.9k, Q4 2020 815.4k, Q1 2021 780.7k, Q2 2021 624.7k -156.0k -156,044 -20.0%
34 FINCH THERAPEUTICS GROUP INC COM COM 325,000 $4.6m0.82% 0.82% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 150.0k, Q2 2021 325.0k +175.0k +175,000 116.7%
35 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 175,000 $4.6m0.81% 0.81% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 175.0k
36 SATSUMA PHARMACEUTICALS INC COM STSA STSA 644,056 $4.5m0.81% 0.81% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 676.3k, Q2 2021 644.1k -32.2k -32,238 -4.8%
37 OVID THERAPEUTICS INC COM OVID OVID 1,124,872 $4.4m0.79% 0.79% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.1m, Q2 2021 1.1m
38 CHARDAN HEALTHCR ACQSTN 2 CO UNIT 99/99/9999 UNIT 99/99/9999 400,000 $4.4m0.78% 0.78% UnchangedShares held: Q3 2020 400.0k, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k
39 NEXTCURE INC COM COM 516,870 $4.2m0.74% 0.74% AddedShares held: Q3 2020 200.0k, Q4 2020 200.0k, Q1 2021 454.0k, Q2 2021 516.9k +62.9k +62,918 13.9%
40 I MAB SPONSORED ADS NBP NBP 46,066 $3.9m0.69% 0.69% ReducedShares held: Q3 2020 150.0k, Q4 2020 150.0k, Q1 2021 250.0k, Q2 2021 46.1k -203.9k -203,934 -81.6%
41 ARK ETF TR GENOMIC REV ETF ARKG ARKG 40,961 $3.8m0.68% 0.68% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.0k, Q2 2021 41.0k +39.0k +38,961 1948.0%
42 RADNET INC COM RDNT RDNT 110,647 $3.7m0.67% 0.67% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 110.6k
43 KADMON HLDGS INC COM KDMN KDMN 936,615 $3.6m0.65% 0.65% UnchangedShares held: Q3 2020 936.6k, Q4 2020 936.6k, Q1 2021 936.6k, Q2 2021 936.6k
44 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 322,730 $3.6m0.63% 0.63% UnchangedShares held: Q3 2020 164.7k, Q4 2020 358.3k, Q1 2021 322.7k, Q2 2021 322.7k
45 AILERON THERAPEUTICS INC COM ALRN ALRN 2,800,000 $3.5m0.63% 0.63% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.8m, Q2 2021 2.8m
46 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 100,000 $3.4m0.60% 0.60% UnchangedShares held: Q3 2020 0, Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k
47 TRICIDA INC COM TCDA TCDA 775,294 $3.3m0.60% 0.60% UnchangedShares held: Q3 2020 23.2k, Q4 2020 858.9k, Q1 2021 775.3k, Q2 2021 775.3k
48 SYNLOGIC INC COM COM 848,354 $3.3m0.59% 0.59% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.5m, Q2 2021 848.4k -644.3k -644,260 -43.2%
49 AMICUS THERAPEUTICS INC COM FOLD FOLD 341,500 $3.3m0.59% 0.59% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 341.5k, Q2 2021 341.5k
50 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 85,063 $3.2m0.58% 0.58% ReducedShares held: Q3 2020 153.0k, Q4 2020 23.6k, Q1 2021 225.9k, Q2 2021 85.1k -140.9k -140,863 -62.4%
51 PLIANT THERAPEUTICS INC COM PLRX PLRX 108,700 $3.2m0.57% 0.57% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 108.7k, Q2 2021 108.7k
52 VIKING THERAPEUTICS INC COM VKTX VKTX 524,754 $3.1m0.56% 0.56% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 724.8k, Q2 2021 524.8k -200.0k -200,000 -27.6%
53 BELLUS HEALTH INC NEW COM NEW BLU BLU 1,010,545 $3.1m0.56% 0.56% AddedShares held: Q3 2020 100.0k, Q4 2020 100.0k, Q1 2021 400.0k, Q2 2021 1.0m +610.5k +610,545 152.6%
54 INCYTE CORP COM INCY INCY 36,533 $3.1m0.55% 0.55% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 23.0k, Q2 2021 36.5k +13.5k +13,521 58.8%
55 BIOATLA INC COM BCAB BCAB 70,160 $3.0m0.53% 0.53% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 70.2k, Q2 2021 70.2k
56 SYNAPTOGENIX INC COM NEW COM NEW 300,000 $3.0m0.53% 0.53% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 300.0k
57 CERECOR INC COM COM 897,330 $2.9m0.52% 0.52% UnchangedShares held: Q3 2020 202.9k, Q4 2020 202.9k, Q1 2021 897.3k, Q2 2021 897.3k
58 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 916,552 $2.9m0.52% 0.52% ReducedShares held: Q3 2020 0, Q4 2020 4.5m, Q1 2021 2.9m, Q2 2021 916.6k -2.0m -1,969,400 -68.2%
59 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 21,825 $2.9m0.51% 0.51% ReducedShares held: Q3 2020 0, Q4 2020 87.1k, Q1 2021 62.1k, Q2 2021 21.8k -40.3k -40,265 -64.8%
60 AERPIO PHARMACEUTICALS INC COM COM 1,676,093 $2.8m0.51% 0.51% ReducedShares held: Q3 2020 3.9m, Q4 2020 475.8k, Q1 2021 2.7m, Q2 2021 1.7m -975.0k -975,000 -36.8%
61 CM LIFE SCIENCES INC COM CL A COM CL A 200,000 $2.8m0.50% 0.50% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
62 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 350,000 $2.8m0.49% 0.49% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 250.0k, Q2 2021 350.0k +100.0k +100,000 40.0%
63 GEMINI THERAPEUTICS INC COM COM 426,455 $2.8m0.49% 0.49% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 684.4k, Q2 2021 426.5k -257.9k -257,924 -37.7%
64 ALLAKOS INC COM ALLKG ALLKG 31,700 $2.7m0.48% 0.48% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 31.7k, Q2 2021 31.7k
65 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 300,454 $2.7m0.48% 0.48% ReducedShares held: Q3 2020 4.7k, Q4 2020 4.7k, Q1 2021 304.7k, Q2 2021 300.5k -4.3k -4,285 -1.4%
66 HEPION PHARMACEUTICALS INC COM COM 1,365,059 $2.7m0.48% 0.48% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
67 SAVARA INC COM SVRA SVRA 1,586,737 $2.7m0.48% 0.48% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.7m, Q2 2021 1.6m -127.6k -127,629 -7.4%
68 IMMATICS N.V SHS IMTX IMTX 225,138 $2.6m0.47% 0.47% ReducedShares held: Q3 2020 638.1k, Q4 2020 638.1k, Q1 2021 255.1k, Q2 2021 225.1k -30.0k -30,000 -11.8%
69 INMUNE BIO INC COM INMB INMB 146,883 $2.6m0.46% 0.46% ReducedShares held: Q3 2020 0, Q4 2020 217.6k, Q1 2021 233.6k, Q2 2021 146.9k -86.7k -86,693 -37.1%
70 YUMANITY THERAPEUTICS INC COM COM 219,470 $2.6m0.46% 0.46% UnchangedShares held: Q3 2020 0, Q4 2020 132.5k, Q1 2021 219.5k, Q2 2021 219.5k
71 LIQUIDIA CORPORATION COM NEW LQDA LQDA 890,435 $2.5m0.45% 0.45% ReducedShares held: Q3 2020 0, Q4 2020 951.4k, Q1 2021 951.4k, Q2 2021 890.4k -61.0k -60,965 -6.4%
72 CATALYST BIOSCIENCES INC COM NEW COM NEW 581,200 $2.5m0.45% 0.45% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 581.2k, Q2 2021 581.2k
73 SUTRO BIOPHARMA INC COM COM 135,360 $2.5m0.45% 0.45% UnchangedShares held: Q3 2020 488.0k, Q4 2020 615.4k, Q1 2021 135.4k, Q2 2021 135.4k
74 SOLID BIOSCIENCES INC COM COM 675,675 $2.5m0.44% 0.44% AddedShares held: Q3 2020 788.0k, Q4 2020 788.0k, Q1 2021 23.6k, Q2 2021 675.7k +652.1k +652,058 2761.0%
75 CYTOKINETICS INC COM NEW CYTK CYTK 120,895 $2.4m0.43% 0.43% ReducedShares held: Q3 2020 55.0k, Q4 2020 227.0k, Q1 2021 127.0k, Q2 2021 120.9k -6.1k -6,105 -4.8%
76 KALVISTA PHARMACEUTICALS INC COM KALV KALV 96,965 $2.3m0.42% 0.42% ReducedShares held: Q3 2020 1.2m, Q4 2020 1.1m, Q1 2021 297.0k, Q2 2021 97.0k -200.0k -200,000 -67.3%
77 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 23,654 $2.3m0.41% 0.41% UnchangedShares held: Q3 2020 23.7k, Q4 2020 23.7k, Q1 2021 23.7k, Q2 2021 23.7k
78 ICAD INC COM NEW ICAD ICAD 128,137 $2.2m0.40% 0.40% ReducedShares held: Q3 2020 181.3k, Q4 2020 195.1k, Q1 2021 217.6k, Q2 2021 128.1k -89.5k -89,500 -41.1%
79 ZOGENIX INC COM NEW ZGNX ZGNX 124,091 $2.1m0.38% 0.38% UnchangedShares held: Q3 2020 182.6k, Q4 2020 174.1k, Q1 2021 124.1k, Q2 2021 124.1k
80 ATRECA INC CL A COM BCEL BCEL 250,000 $2.1m0.38% 0.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 250.0k
81 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 200,000 $2.0m0.36% 0.36% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k
82 CYCLERION THERAPEUTICS INC COM COM 509,924 $2.0m0.36% 0.36% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 300.0k, Q2 2021 509.9k +209.9k +209,924 70.0%
83 INFLARX NV COM IFRX IFRX 666,596 $2.0m0.35% 0.35% ReducedShares held: Q3 2020 149.8k, Q4 2020 149.8k, Q1 2021 699.8k, Q2 2021 666.6k -33.2k -33,154 -4.7%
84 CASI PHARMACEUTICALS INC COM CASI CASI 1,268,154 $2.0m0.35% 0.35% UnchangedShares held: Q3 2020 1.5m, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 1.3m
85 QUANTUM SI INC COM CL A QSI QSI 160,000 $2.0m0.35% 0.35% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 160.0k
86 IMMUNOVANT INC COM IMVT IMVT 185,500 $2.0m0.35% 0.35% NewShares held: Q3 2020 321.9k, Q4 2020 235.6k, Q1 2021 0, Q2 2021 185.5k
87 PASSAGE BIO INC COM COM 145,858 $1.9m0.35% 0.35% UnchangedShares held: Q3 2020 0, Q4 2020 136.7k, Q1 2021 145.9k, Q2 2021 145.9k
88 VASCULAR BIOGENICS LTD COM COM 800,811 $1.9m0.34% 0.34% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 800.8k, Q2 2021 800.8k
89 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 153,941 $1.9m0.34% 0.34% UnchangedShares held: Q3 2020 358.9k, Q4 2020 293.9k, Q1 2021 153.9k, Q2 2021 153.9k
90 DIAMEDICA THERAPEUTICS INC COM NEW DMAC DMAC 415,000 $1.8m0.33% 0.33% UnchangedShares held: Q3 2020 415.0k, Q4 2020 415.0k, Q1 2021 415.0k, Q2 2021 415.0k
91 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 964,100 $1.8m0.32% 0.32% UnchangedShares held: Q3 2020 0, Q4 2020 139.1k, Q1 2021 964.1k, Q2 2021 964.1k
92 MUSTANG BIO INC COM MBIO MBIO 526,003 $1.7m0.31% 0.31% UnchangedShares held: Q3 2020 806.5k, Q4 2020 526.0k, Q1 2021 526.0k, Q2 2021 526.0k
93 FULCRUM THERAPEUTICS INC COM FULC FULC 162,700 $1.7m0.30% 0.30% ReducedShares held: Q3 2020 0, Q4 2020 437.7k, Q1 2021 426.7k, Q2 2021 162.7k -264.0k -264,039 -61.9%
94 BELLICUM PHARMACEUTICALS INC COM NEW BLCM BLCM 500,000 $1.6m0.29% 0.29% UnchangedShares held: Q3 2020 0, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k
95 APPLIED GENETIC TECHNOLOGIES COM AGTC AGTC 415,884 $1.6m0.29% 0.29% UnchangedShares held: Q3 2020 545.9k, Q4 2020 545.9k, Q1 2021 415.9k, Q2 2021 415.9k
96 ACLARIS THERAPEUTICS INC COM ACRS ACRS 89,788 $1.6m0.28% 0.28% ReducedShares held: Q3 2020 0, Q4 2020 300.0k, Q1 2021 188.2k, Q2 2021 89.8k -98.4k -98,412 -52.3%
97 HARPOON THERAPEUTICS INC COM COM 113,600 $1.6m0.28% 0.28% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 268.6k, Q2 2021 113.6k -155.0k -155,000 -57.7%
98 AC IMMUNE SA SHS ACIU ACIU 196,208 $1.6m0.28% 0.28% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 119.8k, Q2 2021 196.2k +76.4k +76,405 63.8%
99 ATYR PHARMA INC COM NEW ATYR ATYR 300,000 $1.5m0.26% 0.26% UnchangedShares held: Q3 2020 0, Q4 2020 400.0k, Q1 2021 300.0k, Q2 2021 300.0k
100 AURIS MEDICAL HOLDING LTD SHS EARS EARS 404,588 $1.4m0.26% 0.26% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 461.5k, Q2 2021 404.6k -56.9k -56,934 -12.3%

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
CURIS INC 1,220,356 $13.8m1.2m shares
PROTHENA CORP PLC PRTA PRTA 437,430 $11.0m437.4k shares
ESSA PHARMA INC EPI EPI 264,868 $7.7m264.9k shares
SERES THERAPEUTICS INC 350,000 $7.2m350.0k shares
SAGE THERAPEUTICS INC SAGE SAGE 91,151 $6.8m91.2k shares
ARDELYX INC ARDX ARDX 1,030,436 $6.8m1.0m shares
LIFESCI ACQUISITION II CORP 512,450 $5.2m512.5k shares
SCHOLAR ROCK HLDG CORP SRRK SRRK 67,059 $3.4m67.1k shares
BCTG ACQUISITION CORP 300,250 $3.3m300.2k shares
ACHIEVE LIFE SCIENCES INC ACHV ACHV 284,151 $3.3m284.2k shares
STRONGBRIDGE BIOPHARMA PLC SBBP SBBP 1,160,450 $3.2m1.2m shares
MORPHIC HLDG INC MORF MORF 49,925 $3.2m49.9k shares
HIGHCAPE CAP ACQUISITION COR 260,000 $3.1m260.0k shares
TCR2 THERAPEUTICS INC TCRR TCRR 136,486 $3.0m136.5k shares
NUVATION BIO INC NUVB NUVB 250,000 $2.6m250.0k shares
ALTIMMUNE INC ALT ALT 181,941 $2.6m181.9k shares
ZAI LAB LTD ZLAB ZLAB 17,000 $2.2m17.0k shares
PDS BIOTECHNOLOGY CORP PDSB PDSB 383,373 $1.7m383.4k shares
MILLENDO THERAPEUTICS INC 1,348,021 $1.6m1.3m shares
VIRACTA THERAPEUTICS INC SNSS SNSS 155,599 $1.4m155.6k shares
SORRENTO THERAPEUTICS INC SRNE SRNE 165,900 $1.4m165.9k shares
RUBIUS THERAPEUTICS INC RUBY RUBY 50,000 $1.3m50.0k shares
ONCONOVA THERAPEUTICS INC 1,145,426 $1.1m1.1m shares
KINIKSA PHARMACEUTICALS LTD 51,273 $949.0k51.3k shares
SYNDAX PHARMACEUTICALS INC SNDX SNDX 40,913 $914.0k40.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
BIOGEN INC BIIB · Call BIIBCall 270,000 $93.5m270.0k shares Reduced
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 300,000 $50.9m300.0k shares New
INTELLIA THERAPEUTICS INC NTLA · Call NTLACall 294,400 $47.7m294.4k shares New
ALNYLAM PHARMACEUTICALS INC ALNY · Call ALNYCall 195,700 $33.2m195.7k shares New
CRISPR THERAPEUTICS AG CRSP · Put CRSPPut 200,000 $32.4m200.0k shares Added
CASSAVA SCIENCES INC FLNA · Call FLNACall 365,000 $31.2m365.0k shares New
REATA PHARMACEUTICALS INC RETA · Put RETAPut 174,900 $24.8m174.9k shares Added
HORIZON THERAPEUTICS PUB L HZNP · Call HZNPCall 250,000 $23.4m250.0k shares Reduced
CELLDEX THERAPEUTICS INC NEW CLDX · Call CLDXCall 600,000 $20.1m600.0k shares Added
APELLIS PHARMACEUTICALS INC APLS · Put APLSPut 300,000 $19.0m300.0k shares New
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 300,000 $19.0m300.0k shares New
INCYTE CORP INCY · Call INCYCall 200,000 $16.8m200.0k shares Unchanged
BAUSCH HEALTH COS INC BHC · Call BHCCall 550,000 $16.1m550.0k shares Reduced
ZOGENIX INC ZGNX · Call ZGNXCall 850,000 $14.7m850.0k shares Unchanged
SAGE THERAPEUTICS INC SAGE · Call SAGECall 254,300 $14.4m254.3k shares Added
SAGE THERAPEUTICS INC SAGE · Put SAGEPut 250,000 $14.2m250.0k shares Unchanged
CHEMOCENTRYX INC CCXI · Put CCXIPut 967,600 $13.0m967.6k shares Added
SERES THERAPEUTICS INC Call Call 500,000 $11.9m500.0k shares Reduced
RAPT THERAPEUTICS INC Put Put 350,000 $11.1m350.0k shares New
ARK ETF TR ARKG · Put ARKGPut 119,900 $11.1m119.9k shares Reduced
ARENA PHARMACEUTICALS INC ARNA · Call ARNACall 150,000 $10.2m150.0k shares Unchanged
OCULAR THERAPEUTIX INC OCUL · Call OCULCall 700,000 $9.9m700.0k shares Added
FATE THERAPEUTICS INC FATE · Put FATEPut 100,000 $8.7m100.0k shares Reduced
INTRA-CELLULAR THERAPIES INC ITCI · Call ITCICall 210,000 $8.6m210.0k shares Unchanged
MACROGENICS INC MGNX · Call MGNXCall 300,000 $8.1m300.0k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15